Audit 296444

FY End
2022-12-31
Total Expended
$2.14M
Findings
6
Programs
3
Year: 2022 Accepted: 2024-03-21
Auditor: Armanino

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
382832 2022-003 Material Weakness - B
382833 2022-004 Material Weakness - B
382834 2022-005 Material Weakness - B
959274 2022-003 Material Weakness - B
959275 2022-004 Material Weakness - B
959276 2022-005 Material Weakness - B

Programs

ALN Program Spent Major Findings
93.859 Biomedical Research and Research Training $135,670 Yes 1
93.865 Child Health and Human Development Extramural Research $74,703 Yes 1
93.855 Allergy, Immunology and Transplantation Research $31,837 Yes 0

Contacts

Name Title Type
K6YFV76PCGB7 Peter Slover Auditee
8583665548 Stacie Cornwell Auditor
No contacts on file

Notes to SEFA

Accounting Policies: The accompanying schedule of expenditures of federal awards (the "Schedule") includes the federal award activity of ABS Institute under programs of the federal government for the year ended December 31, 2022. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of the ABS Institute, it is not intended to and does not present the financial position, changes in net assets, or cash flows of the ABS Institute. Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Amounts passed through to subrecipients are reported on the Schedule when the disbursement is made to the subrecipient. De Minimis Rate Used: N Rate Explanation: Applied Biomedical Science Institute has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance. Applied Biomedical Science Institute has a negotiated provisional indirect cost rate of 92.40% for use during the year ended December 31, 2022.

Finding Details

Finding number: 2022-003: Allowable Costs/Cost Principles, Period of Performance and Subreceipient Monitoring, Research & Development Cluster Criteria: Per Part 6 of the Compliance Supplement, controls need to be designed such that they would prevent or detect potential noncompliance. Management should implement control activities through policies. Condition: ABS Institute does not have documented policies regarding the process and controls in place surrounding the methodology utilized to allocate costs to grants. ABS Institute does not have documented policies regarding the process and controls in place surrounding documenting title, job description and pay rate for employees. ABS Institute does not have documented policies regarding the process and controls in place surrounding the review and approval of credit card purchases and any other purchases/payments made outside of bill.com system. ABS Institute does not have documented policies regarding the process and controls in place surrounding the review and approval of accrued expenses included in the Schedule of Expenditures of Federal Awards. ABS Institute does not have documented policies regarding the process and controls in place surrounding subrecipient monitoring. Cause: ABS Institute was recently formed, so documentation and implementation of processes is still in process. Effect or potential effect: Possibility of unallowable costs allocated to grants. Possibility of grant funds drawn down without documentation to support costs incurred. Possibility of subrecipient expending federal funds for unallowable costs. Identification as a repeat finding: This is a repeat finding from the immediate previous audits, 2021-003 and 2020- 001. Recommendation: We recommend that ABS Institute document policies regarding the process and controls in place related to the areas as noted above. Views of responsible official: ABS Institute is in the process of putting in place the appropriate documentation with a proposed completion
Finding number: 2022-004: Allowable Costs/Cost Principles, Research & Development Cluster Criteria: Per Part 3 of the Compliance Supplement, charges to Federal awards for salaries and wages must be based on records that accurately reflect the work performed. These records must: (i) Be supported by a system of internal control which provides reasonable assurance that the charges are accurate, allowable, and properly allocated (ii) Be incorporated into the official records of the non-Federal entity. Condition: ABS Institute was unable to provide support documenting title, job description and pay rate for multiple employees. Cause: Documentation of title, job description and pay rate was not maintained. Effect or potential effect: Possibility of unallowable costs allocated to grants. Identification as a repeat finding: This is a repeat finding from the immediate previous audits, 2021-004 and 2020- 003. Recommendation: We recommend that ABS Institute retain documentation to support employee’s title, job description and pay rate. Views of responsible official: ABS Institute has made the following changes in response to this finding: In connection with pay increases that were completed in January 2023, we put in place written documentation for each employee related to their title and pay rate. In addition, all employees hired in 2022 and 2023 have an executed offer letter
Finding number: 2022-005: Allowable Costs/Cost Principles, Research & Development Cluster Criteria: Per Part 3 of the Compliance Supplement, for costs that are being allocated, costs must be allocated uniformly across all programs. Condition: ABS Institute utilizes cost allocation memorandums to allocate costs to the grant. Several months of non-payroll costs were not allocated to programs in line with ABS Institute's cost allocation memorandums. Cause: ABS Institute does not have a formal review process in place to ensure all allocations are appropriately applied. Effect or potential effect: Possibility of unallowable costs allocated to grants. Identification as a repeat finding: This is a repeat finding from the immediate previous audit, 2021-005. Recommendation: We recommend that ABS Institute implement a formal review policy to ensure that non-payroll costs are allocated in line with cost allocation memorandums. Views of responsible official: ABS Institute has made the following changes in response to this finding: On a monthly basis, the allocations are provided to ABS Institute from our 3rd party bookkeeper. The allocation process does not change from month-to-month. On an adhoc basis, a review of the monthly allocations was completed in 2023.
Finding number: 2022-003: Allowable Costs/Cost Principles, Period of Performance and Subreceipient Monitoring, Research & Development Cluster Criteria: Per Part 6 of the Compliance Supplement, controls need to be designed such that they would prevent or detect potential noncompliance. Management should implement control activities through policies. Condition: ABS Institute does not have documented policies regarding the process and controls in place surrounding the methodology utilized to allocate costs to grants. ABS Institute does not have documented policies regarding the process and controls in place surrounding documenting title, job description and pay rate for employees. ABS Institute does not have documented policies regarding the process and controls in place surrounding the review and approval of credit card purchases and any other purchases/payments made outside of bill.com system. ABS Institute does not have documented policies regarding the process and controls in place surrounding the review and approval of accrued expenses included in the Schedule of Expenditures of Federal Awards. ABS Institute does not have documented policies regarding the process and controls in place surrounding subrecipient monitoring. Cause: ABS Institute was recently formed, so documentation and implementation of processes is still in process. Effect or potential effect: Possibility of unallowable costs allocated to grants. Possibility of grant funds drawn down without documentation to support costs incurred. Possibility of subrecipient expending federal funds for unallowable costs. Identification as a repeat finding: This is a repeat finding from the immediate previous audits, 2021-003 and 2020- 001. Recommendation: We recommend that ABS Institute document policies regarding the process and controls in place related to the areas as noted above. Views of responsible official: ABS Institute is in the process of putting in place the appropriate documentation with a proposed completion
Finding number: 2022-004: Allowable Costs/Cost Principles, Research & Development Cluster Criteria: Per Part 3 of the Compliance Supplement, charges to Federal awards for salaries and wages must be based on records that accurately reflect the work performed. These records must: (i) Be supported by a system of internal control which provides reasonable assurance that the charges are accurate, allowable, and properly allocated (ii) Be incorporated into the official records of the non-Federal entity. Condition: ABS Institute was unable to provide support documenting title, job description and pay rate for multiple employees. Cause: Documentation of title, job description and pay rate was not maintained. Effect or potential effect: Possibility of unallowable costs allocated to grants. Identification as a repeat finding: This is a repeat finding from the immediate previous audits, 2021-004 and 2020- 003. Recommendation: We recommend that ABS Institute retain documentation to support employee’s title, job description and pay rate. Views of responsible official: ABS Institute has made the following changes in response to this finding: In connection with pay increases that were completed in January 2023, we put in place written documentation for each employee related to their title and pay rate. In addition, all employees hired in 2022 and 2023 have an executed offer letter
Finding number: 2022-005: Allowable Costs/Cost Principles, Research & Development Cluster Criteria: Per Part 3 of the Compliance Supplement, for costs that are being allocated, costs must be allocated uniformly across all programs. Condition: ABS Institute utilizes cost allocation memorandums to allocate costs to the grant. Several months of non-payroll costs were not allocated to programs in line with ABS Institute's cost allocation memorandums. Cause: ABS Institute does not have a formal review process in place to ensure all allocations are appropriately applied. Effect or potential effect: Possibility of unallowable costs allocated to grants. Identification as a repeat finding: This is a repeat finding from the immediate previous audit, 2021-005. Recommendation: We recommend that ABS Institute implement a formal review policy to ensure that non-payroll costs are allocated in line with cost allocation memorandums. Views of responsible official: ABS Institute has made the following changes in response to this finding: On a monthly basis, the allocations are provided to ABS Institute from our 3rd party bookkeeper. The allocation process does not change from month-to-month. On an adhoc basis, a review of the monthly allocations was completed in 2023.